JSPR - Jasper Therapeutics Chief Financial Officer Awarded $357K Worth of Stock Options | Benzinga
Herb Cross, Chief Financial Officer at Jasper Therapeutics (NASDAQ:JSPR), reported a large acquisition of company stock options on September 26, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Cross, Chief Financial Officer at Jasper Therapeutics, a company in the Health Care sector, was just awarded stock options worth 550,000 shares of JSPR. The options give Cross the right to buy the company's stock at $0.78 per share.
Jasper Therapeutics shares are trading down 4.0% at $0.65 at the time of this writing on Wednesday morning. Since the current price is $0.65, this makes Cross's 550,000 shares worth $357,445.